Drug Filter >
  • Status: IND Filing
  •   > 
Drug Filter
Category:
Chemicals (77) Biologics (3)
Clinical Stage:
Pending (1) Active (53) Discontinued (1)
Company:
Jiangsu Hengrui Medicine (5) Shanghai Hengrui (4) Shanghai Institute of Materia Medica, Chinese Academy of Sciences (4) Chiatai Tianqing (CTTQ) (3) Kanion Pharmaceutical (3) Zhongsheng Pharmacy (3) Chengdu Shengdi (2) Cisen Pharmaceutical (2) HEC Pharm (2) Hangzhou Adamerck Pharmlabs (2) Jiangsu Shengdi (2) Sanofi (2) WuXi AppTec (2) Zhejiang Yongning Pharmaceutical (2) 302 Military Hospital of China (1) Anke Biotechnology (1) BCN Peptides (1) Baiyunshan Pharmaceutical (1) Beijing Fengshuo Weikang (1) Beijing Molike Technology (1) Beijing Ruiyunhai Biotechnology (1) Chengdu Yiping Pharmaceutical Technology (1) China State Institute of Pharmaceutical Industry (CSIPI) (1) Chinese PLA General Hospital/Medical School of Chinese PLA (1) Chongqing Fujin Biomedical (1) Chongqing University of Arts and Sciences (1) Dalian Dien Biological Engineering (1) Dermata (1) DiverDrugs (1) Dongguan Anhao (1) Dongguan Daxin (1) Eleven (1) Foreland Pharma (1) Fujian Jinshon Biologicalpharmaceutical (1) GNI Group (1) Guangzhou Xiangxue Pharmaceuticals (1) Guangzhou Yinnuo Pharmaceutical (1) Hangzhou Advenchen Laboratories (1) Hangzhou Pharmavaxin (1) Hangzhou Ruomaixing (1) Hangzhou Tianlong Pharmaceuticals (1) Hangzhou Zhongmei Huadong Pharmaceutical (1) Hansoh Pharma (1) Huadong Medicine (1) ImQuest BioSciences (1) Immune Pharmaceuticals (1) Innocare (1) Institute of Materia Medica Chinese Academy of Medical Sciences (1) Institute of Pharmacology & Radiation of AMMS (1) Institute of Pharmacology & Toxicology of AMMS (1) Jianfeng Pharmaceutical (1) Jiangsu Aosaikang Pharmaceutical (1) Jiangsu Medolution (1) Jingfeng Pharma (1) Kelun Pharmaceutical (1) Liaoning Haisike pharmaceutical (1) Livzon Group (1) Livzon Group Livzon Pharmaceutical Factory (1) Luye Pharma (1) Merck Serono (1) Nanjing Advenchen Laboratories (1) Nanjing Tech University (1) Nanjing Zhongrui Medcine (1) Ningbo Shengjian (1) Ningbo Ziyuan Pharmaceutical (1) NuoKang Biopharma (1) Ocean University of China (1) Penglai Nuokang Pharmaceutical (1) Puyi chemical/Gyrochem (1) Qingdao Huanghai Pharmaceutical (1) Qingdao University (1) Roche (1) Sanhome Pharmaceutical (1) Shandong Provincial Institute of Dermatology and Venereology (1) Shanghai Genomics (1) Shanghai Haihe Pharmaceutical (1) Shanghai Newsummit Biopharma (1) Shanghai Pharma (1) Shanghai Shaletech Technology (1) Shenyang Pharmaceutical University (1) Shijiazhuang Zhongqi Pharmaceutical (1) Sichuan Haisco Pharmaceutical (1) Sichuan Yibin Wuliangye Yibin Pharmaceutical (1) Signum Dermalogix (1) Simcere (1) Sinopharm A-THINK Pharmaceutical (1) Sirnaomics (1) Southeast Pharmaceuticals (1) Suzhou Sirnaomics Biopharmaceuticals (1) Tasly Pharm (1) Teligene (1) Tianjin Institute of Pharmaceutical Research (1) Wuhan Kangliyuan (1) XuanZhu Pharma (1) Zai Lab (1) Zhaoke Pharmaceutical (1) Zhejiang Forever Medicine (1) Zhejiang University (1) 吉林英联尚德科技开发 (1) 浙江浙北药业 (1) 未知 (0)
Indication:
Acne (1) Alzheimer's disease (AD) (3) Arrhythmia (1) Brain ischemia (1) Breast cancer (4) Cerebral infarction (1) Chronic pain (1) Circulation disturbance (1) Anaplastic lymphoma kinase (ALK)-positive NSCLC (1) Diabetic macular edema (1) Endometrial cancer (1) Endometriosis (1) Epilepsy/Seizures (1) Erectile dysfunction (ED) (1) Gastric cancer (2) Generalized tonic-clonic status epilepticus (GTCSE) (1) Glioblastoma multiforme (1) Gram-positive and Gram-negative bacterial infections (1) HBV infection (1) Dyskinesia (1) HCV infection (4) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hypertension (1) Idiopathic pulmonary fibrosis (IPF) (1) Lung cancer (2) Malignancies (1) Medullary thyroid cancer (MTC) (1) Melanoma (1) Multiple myeloma (MM) (1) Myocardial infarction (MI) (2) Non small cell lung cancer (NSCLC) (8) Non-alcoholic fatty liver disease (NAFLD) (1) Obesity (2) Osteoarthritis (OA) (3) Ovarian cancer (2) Pancreatic cancer (1) Parkinson's disease (PD) (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (4) Solid tumours (5) Stable plaque psoriasis (1) Systemic lupus erythematosus (2) Thyroid cancer (1) Tuberculosis (1) Type 2 diabetes (6) Uveitis (1) Venous thromboembolism (VTE) (1) Cardiac ischemic complications (1) Systemic bacterial infections (3) Colon cancer (2) Chronic heart failure (2) Pain (2) Anesthesia (1) HER2-positive metastatic breast cancer (1) Renal carcinoma (2) Hyperphosphatemia (1) Gastrointestinal motility disorders (1) Ischemic stroke (1) Esophagus cancer (1) Gout (1) Thrombosis (2) Alopecia (1) Diffuse large B cell lymphoma (1) Skin hypertrophic scars (1) Urinary tract stones (1) Liver cancer (2) Liver failure (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:

CopyRight©2017药渡经纬信息科技(北京)有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码